Clinical Trial Update: Hematopoietic Cell Transplantation for Patients With Hematologic Malignancies Using Related, HLA-Haploidentical Donors [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update on hematopoietic cell transplantation for hematologic malignancies using related, HLA-haploidentical donors.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hematologic Neoplasms

Snippet

Sponsor: European Institute of Oncology | Conditions: Hematologic Neoplasms | Phase 2 | Status: UNKNOWN